WitrynaA. The latest price target for Immutep ( NASDAQ: IMMP) was reported by Ladenburg Thalmann on Tuesday, August 3, 2024. The analyst firm set a price target for 8.30 … WitrynaImmutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and …
Immutep (IMMP) Stock Price & Analysis - TipRanks
WitrynaThe Immutep stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge … Witryna30 mar 2024 · Delayed Australian Stock Exchange - 01:10:35 2024-03-30 am EDT. 0.2650. AUD. +1.92%. 05:31p. Immutep Agrees to Expand Trial Evaluating Combination of Eftilagimod Alpha in First Line Non-Small Cell Lung Cancer. MT. 08:01a. Immutep Announces Expansion of Triple Combination Therapy in 1st Line Non-Small Cell Lung … city fort lauderdale building permit
IMMUTEP ADR • Hauptdiskussion
Witryna11 kwi 2024 · The official website for the company is www.immutep.com. The biotechnology company can be reached via phone at (128) 315-7003, via email at … Witryna23 lis 2024 · Real-time trade and investing ideas on Immutep LTD ADR IMMP from the largest community of traders and investors. ... Not an offer or recommendation by … Witryna6 kwi 2024 · Headline. Immutep Announces Promising Initial Clinical Data from INSIGHT-003 at SITC 2024. finance.yahoo.com - November 10 at 5:23 PM. Immutep … city for the nations lexington ky